Synergy CHC (SNYR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting is scheduled for June 18, 2025, and will be held virtually via live webcast, with registration required by June 17, 2025.
Stockholders will vote on four key proposals: election of five directors, ratification of the independent auditor, amendment to the equity incentive plan, and amendment to authorize preferred stock issuance.
The board recommends approval of all proposals and encourages electronic voting to conserve resources and reduce costs.
Voting matters and shareholder proposals
Proposal 1: Elect five directors for one-year terms expiring in 2026.
Proposal 2: Ratify RBSM LLP as independent auditors for fiscal year ending December 31, 2025.
Proposal 3: Approve amendment to the 2024 Equity Incentive Plan, increasing shares available for issuance to 2,252,102.
Proposal 4: Approve amendment to Articles of Incorporation to authorize up to 1,000,000 shares of preferred stock.
Board recommends a vote “FOR” all proposals; voting can be done online, by mail, or at the meeting.
Board of directors and corporate governance
Five directors are nominated: Jack Ross, Alfred Baumeler, J. Paul SoRelle, Nitin Kaushal, and Scott Woodburn.
Board committees include Audit, Compensation, and Nominating and Corporate Governance, with independent directors chairing each.
The board held one meeting in 2024; all directors attended at least 75% of meetings.
The company has a combined Chairman and CEO role, currently held by Jack Ross.
A Code of Business Ethics and Conduct applies to all directors, officers, and employees.
Latest events from Synergy CHC
- Q3 sales fell on rebranding, but profitability, liquidity, and growth plans remain strong.SNYR
Q3 202411 Jan 2026 - All director nominees and key proposals were approved, with results to be filed with the SEC.SNYR
AGM 20256 Jan 2026 - Profitability maintained amid revenue decline; IPO and new launches set stage for 2025 growth.SNYR
Q4 202426 Dec 2025 - Shelf registration for $100M in securities, with $5.69M ATM offering to fund growth and expansion.SNYR
Registration Filing16 Dec 2025 - Stockholders to vote on director elections, auditor, equity plan, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor, equity plan expansion, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Health and wellness firm targets Nasdaq IPO to fund growth amid strong 2023 results and high debt.SNYR
Registration Filing30 Nov 2025 - Consumer health company targets Nasdaq IPO to fund growth amid high debt and concentrated sales.SNYR
Registration Filing30 Nov 2025 - IPO aims to fund brand growth and expansion amid recent financial improvement and high leverage.SNYR
Registration Filing30 Nov 2025